Transcripts
Amneal Pharmaceuticals (AMRX) earnings call transcripts
Earnings call transcripts for Amneal Pharmaceuticals, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
The call portrayed raised guidance as broad-based, with biosimilars, complex generics and capacity expansion driving the next leg.
Jul 30, 2026Confident0.86